EIF2AK3: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
 
(One intermediate revision by the same user not shown)
Line 24: Line 24:
[[Category:Medical genetics]]
[[Category:Medical genetics]]
{{medicine-stub}}
{{medicine-stub}}
{{No image}}
__NOINDEX__

Latest revision as of 10:24, 17 March 2025

EIF2AK3 (Eukaryotic Translation Initiation Factor 2 Alpha Kinase 3) is a protein that in humans is encoded by the EIF2AK3 gene. This protein is part of the PERK pathway, which plays a crucial role in the Unfolded Protein Response (UPR). The UPR is activated in response to an accumulation of unfolded or misfolded proteins in the endoplasmic reticulum (ER).

Function[edit]

EIF2AK3 is an enzyme that acts as a protein kinase. It phosphorylates the alpha subunit of eukaryotic translation-initiation factor 2 (EIF2), leading to its inactivation and thus to a rapid reduction of translational initiation and repression of global protein synthesis. This is a necessary step in triggering the unfolded protein response (UPR).

Clinical significance[edit]

Mutations in the EIF2AK3 gene are associated with Wolcott-Rallison Syndrome, a rare autosomal recessive disorder characterized by early-onset diabetes mellitus, epiphyseal dysplasia, and other variable clinical manifestations.

See also[edit]

References[edit]

<references />

Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!